Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Journal of Cellular Biochemistry|October 25, 2002
Retinoid signalling and gene expression in neuroblastoma cells: RXR agonist and antagonist effects on CRABP-II and RARbeta expressionQuentin Campbell Hewson, Penny E Lovat, Andrew D J Pearson, et al.
Pediatric Blood & Cancer|April 21, 2010
Glomerular toxicity persists 10 years after ifosfamide treatment in childhood and is not predictable by age or doseRoderick Skinner, Annie Parry, Lisa Price, et al.
European Journal of Cancer (Oxford, England : 1990)|October 24, 2009
Persistent nephrotoxicity during 10-year follow-up after cisplatin or carboplatin treatment in childhood: relevance of age and dose as risk factorsRoderick Skinner, Annie Parry, Lisa Price, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 5, 2004
Cyclophosphamide metabolism in children with non-Hodgkin's lymphomaS Murray Yule, Lisa Price, Alex D McMahon, et al.
Pediatric Blood & Cancer|December 2, 2022
Systematic review of clinical drug development activities for neuroblastoma from 2011 to 2020Jaclynne H Nader, Florence Bourgeois, Rochelle Bagatell, et al.
Biochemical Pharmacology|February 14, 2002
Influence of isomerisation on the growth inhibitory effects and cellular activity of 13-cis and all-trans retinoic acid in neuroblastoma cellsGareth J Veal, Julie Errington, Christopher P F Redfern, et al.
The Lancet. Oncology|March 1, 2008
High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trialAndrew D J Pearson, C Ross Pinkerton, Ian J Lewis, et al.
Leukemia Research|June 14, 2011
Adaptation of the plasma inhibitory activity assay to detect Aurora, ABL and FLT3 kinase inhibition by AT9283 in pediatric leukemiaJennifer E Podesta, Richard Sugar, Matt Squires, et al.
Molecular Oncology|December 22, 2015
Novel pharmacodynamic biomarkers for MYCN protein and PI3K/AKT/mTOR pathway signaling in children with neuroblastomaJennifer R Smith, Lucas Moreno, Simon P Heaton, et al.
Clinical Pharmacology and Therapeutics|October 27, 2023
Rescuing Drugs That are Discontinued in Adult Oncology Development for the Benefit of Children and Adolescents With Cancer - An ACCELERATE Multistakeholder ConsensusTeresa de Rojas, Davy Chiodin, Andrew D J Pearson, et al.
Pageof 12